Brooks Laboratories Ltd
Brooks Laboratories Ltd Share Price Today: Live Updates & Key Insights
Get insights on Brooks Laboratories Ltd’s fundamentals, financials, shareholding, peer comparison, corporate actions & performance. Track key metrics, price trends & market sentiment for informed decisions. Explore all data at Motilal Oswal.
Brooks Laboratories Ltd Share Price Chart
Brooks Laboratories Ltd Fundamentals
Traded Volume: 22,759
Market Cap(Cr): 313
Avg Traded Price 67.87
1 Year return -27.02%
Upper Circuit 106.9
Lower Circuit 103.4
P/E TTM -766.00
P/B Ratio 0.00
Traded Value(Cr) 24.15
EPS TTM -0.139
Book value -0.139
Dividend 0.00%
Brooks Laboratories Ltd Share Price Performance
Shows the percentage change in stock price over different time periods
This section highlights Brooks Laboratories Ltd stock price performance across key timeframes, including 1-week, 1-month, 3-month, Year-To-Date (YTD), and 1-year returns. It provides insights into the Brooks Laboratories Ltd share price history, short-term movements, long-term trends, and overall investor sentiment
1W -4.94%
1M -18.88%
3M -30.03%
1Y -27.02%
YTD -42.74%
Brooks Laboratories Ltd Traded Volume Movement
Shows the trading volume over different time periods
This section highlights Brooks Laboratories Ltd daily and average traded volumes, offering insights into investor activity and market liquidity. Higher volumes than average often indicate rising interest, news impact, or shifting market sentiment
Yesterday 56818.00
Day Before Yesterday 13588.00
1W Avg 37006.50
1M Avg 50019.76
3M Avg 41438.31
Brooks Laboratories Ltd Technical Details
Brooks Laboratories Ltd technical indicators, such as support and resistance levels and pivot points, are calculated based on historical price and volume trends. These metrics help traders anticipate possible price movements and make informed trading decisions.
Support 1 104
Support 2 102
Support 3 101
Pivot Point : 105
Resistance 1 108
Resistance 2 109
Resistance 3 111
Brooks Laboratories Ltd Corporate Actions
Brooks Laboratories Ltd corporate actions include dividends, bonus issues, stock splits, and key company updates that may affect share price and investor sentiment. This section provides timely details on past and upcoming actions, including ex-date, record date, and payout ratio - helping investors make informed decisions based on Brooks Laboratories Ltd’s capital allocation strategies.
All
Ex-Date 28-Jul-2023 Type R Description /share@1:16% Record Date 28-Jul-2023 Ratio 1:16
Ex-Date 11-Feb-2020 Type R Description /share@9:20% Record Date 12-Feb-2020 Ratio 9:20
Dividends
No Dividend has been declared by BROOKS
Bonus
No Bonus has been declared by BROOKS
Splits
No Split has been declared by BROOKS
Others
Ex-Rights Date 28-Jul-2023 Premium(Rs.) 65.00 Ratio 1:16
Ex-Rights Date 11-Feb-2020 Premium(Rs.) 10.00 Ratio 9:20
Brooks Laboratories Ltd Peer Comparison
Shows key financial metrics for the company and its peers
This section compares Brooks Laboratories Ltd with leading peers in the banking sector based on key metrics such as market capitalization, 1-year return, P/E (TTM), and PB ratio. It helps investors evaluate Brooks Laboratories Ltd's relative performance and valuation against major competitors.
Stock Name Zim Laboratories Ltd ₹71.03 (+0.30%) M. Cap (Cr) 3.46 1 Yr Return (%) -38.86% P/E (TTM) 36.84 PB Ratio 1.37
Stock Name Lyka Labs Ltd ₹94.07 (+0.50%) M. Cap (Cr) 3.36 1 Yr Return (%) -37.24% P/E (TTM) 44.71 PB Ratio 3.39
Stock Name Nectar Lifescience Ltd ₹14.68 (+4.78%) M. Cap (Cr) 3.29 1 Yr Return (%) -61.48% P/E (TTM) -1.83 PB Ratio 0.34
Stock Name Brooks Laboratories Ltd ₹106.11 (+0.86%) M. Cap (Cr) 3.13 1 Yr Return (%) -27.02% P/E (TTM) -765.92 PB Ratio 5.01
Stock Name Zenotech Laboratories Ltd ₹51.12 (+1.57%) M. Cap (Cr) 3.12 1 Yr Return (%) -39.62% P/E (TTM) 101.52 PB Ratio 3.35
Stock Name Sat Kartar Shopping Ltd ₹190.90 (-0.05%) M. Cap (Cr) 3.01 1 Yr Return (%) NaN% P/E (TTM) 30.62 PB Ratio 14.01
Stock Name Aarey Drugs & Pharmaceuticals Ltd ₹97.26 (-2.01%) M. Cap (Cr) 2.76 1 Yr Return (%) +48.06% P/E (TTM) 66.35 PB Ratio 2.07
Brooks Laboratories Ltd Cash Flow
Cash flow data provides a view of how money is generated and spent by Brooks Laboratories Ltd, across its operating activities, investing activities, and financing activities.
PARTICULARS Operating Activities Mar 2025 2.52 Mar 2024 -9.68 Mar 2023 0.56 Mar 2022 3.12 Mar 2021 -0.90
PARTICULARS Investing Activities Mar 2025 -45.97 Mar 2024 0.18 Mar 2023 -0.40 Mar 2022 1.12 Mar 2021 -0.75
PARTICULARS Financing Activities Mar 2025 43.36 Mar 2024 9.60 Mar 2023 -0.22 Mar 2022 -4.22 Mar 2021 1.31
PARTICULARS Net Cash Flow Mar 2025 -0.08 Mar 2024 0.10 Mar 2023 -0.06 Mar 2022 0.02 Mar 2021 -0.33
Brooks Laboratories Ltd Shareholding Pattern
This shows the ownership breakdown of Brooks Laboratories Ltd, highlighting participation from Foreign Institutional Investors (FII), Mutual Funds, Public, Other Institutions, and Promoters.
Promoter 52.62%
Public 37.0%
Other Institutions 0.48%
FII 0.01%
Mutual Funds 9.9%
About Brooks Laboratories Ltd
Brooks Laboratories Limited was incorporated on January 23, 2002. The company was initially promoted for manufacturing latest molecules in Injectables, tablets and dry syrups for the domestic customers. Brooks Laboratories is a pharmaceutical manufacturing company working on contract basis. The company has manufacturing plants at Baddi, Himachal Pradesh and Vadodara, Gujarat. Both the units are cGMP compliant in conformity with national and international standards. The Vadodara facility of the company has been approved by European Medicine agency. The company has a wide range of products catering to critical care segment in Parental Section like Beta Lactam, Cephalosporin & General Dry powder Injectables, Ampoules and Liquid vials, Dry Syrups and Tablets etc. Their product portfolio presently comprises of 28 Injectables, 19 Tablets and 2 Dry Syrups which are marketed domestically.The company's manufacturing facilities are designed to manufacture a variety of products in the formulation segment using a combination of processes. At Baddi, they manufacture wide range of products under the formulation segment for various top notch companies of India.The company's major clients are companies like Zydus Cadila, Aristo Pharmaceuticals Pvt Ltd, FDC Ltd, Nectar Lifesciences Ltd, Sanat Products Ltd, Hetero Healthcare Ltd, Medley Pharmaceuticals, Wockhardt Ltd, Parental Drugs, Chanderbhagat Pharma and Alembic Ltd etc. Their major suppliers of raw materials are Rajasthan Antibiotics Ltd, Aurobindo Pharma Ltd, DSM Anti Infectives Ltd and Qilu Pharmaceutical Company Ltd.With roots dating back to 2002, Brooks Laboratories were established with a sole purpose of being a pioneer in the Pharmaceutical industry. Right from its inception, the company has entrenched strong foothold in the Pharmaceutical business and has successfully been a prominent part of Pharmaceutical Formulation Development, Pharmaceutical Production, Pharmaceutical Exports, etc. Starting out as Manufacturer for various Pharmaceutical products in India and abroad, over the years with sheer hard work, the Company earned its valuable name in India and abroad. The Company has a world's largest dedicated EU certified plant at Vadodara.In the year 2006, the company set up a facility for manufacturing Tablets, Dry Syrup and Injectables, which was supported by a research and development (R&D) centre at Baddi, Himachal Pradesh. In May 2006, they started their operations and in June 3, 2006, they commenced commercial production.In October 2006, the company obtained Import license from Drugs Controller General of India under the Drugs Act 1940 and Drugs Rules. In August 2007, they received an AS/NZS ISO 9001:2000 Certificate from SAI Global Certification Services Pty Ltd, Australia. In April 2008, the company took over some of the assets of Brooks Pharmaceuticals, a partnership firm of the promoters, Atul Ranchal & Rajesh Mahajan.In April 2010, the manufacturing facility at Baddi was certified as WHO GMP compliant by Department of Health & Family Welfare, HP. In July 2010, the company received an ISO 9001:2008 Certificate from UKAS Quality Management, URS & IAF.In August 2011, Brooks Laboratories raised money by way of Initial Public Offer Rs. 63 Crore from public. During the financial year ended 31 March 2014, the company operated the Baddi plant at 100% capacity. During the financial year ended 31 March 2015, the company operated the Baddi plant at 100% capacity. During the financial year ended 31 March 2016, the company operated the Baddi plant at 92% capacity.On 7 March 2017, Brooks Laboratories' world class dedicated carbapenem facility in Vadodara Plant started manufacturing activity. Brooks Management decided to upgrade the facility in line with cGMP in Baddi plant. Since it was a running unit, the company decided to upgrade the Baddi facility in steps. As a first step, the company upgraded one injectable manufacturing line, which started commercial production in November 2016. The company operated the Baddi plant at 92% capacity during the year under review.The upgradation of injectable line in Baddi facility was carried out for 3 months from June 2017, whereby production in injectable line was affected, upgradation was completed and production started from September onwards in Baddi facility. The company commenced production in August 2017 at Baddi Plant with almost double the capacity of previous line.The Company started production and sales at its manufacturing facility in Vadodara in 2019-20.
Whole Time Director
Jitendra Pratap Singh
Registered office Village Kishanpura, Nilagarh Road Baddi, Solan, Himachal Pradesh, 174101
FAX :91-1795-654001/02/03
Background
Incorporation Year 2002
Face Value ₹10.00
Market Lot 1
FAQs on Brooks Laboratories Ltd
How to buy Brooks Laboratories Ltd shares on NSE?
To buy Brooks Laboratories Ltd shares in Motilal Oswal, you just need to open a demat account and get your KYC documents verified.
What is the Brooks Laboratories Ltd share price today?
The Brooks Laboratories Ltd share price on NSE is ₹106.11 today.
What is the market cap of Brooks Laboratories Ltd on NSE?
The company has a market capitalization of ₹312.57.
What is the PE & PB ratio of Brooks Laboratories Ltd?
PE is -766 and PB is 0.
What is the 52 Week High and Low of Brooks Laboratories Ltd shares?
Brooks Laboratories Ltd stock price high: ₹198.86 Brooks Laboratories Ltd stock price low: ₹95.55.